NL-OMON32563尚未招募2 期
A randomized double blind placebo controlled ascending dose study to evaluate the effect of APL180 on endothelial function in patients with familial hypercholesterolemia - APL180
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- ovartis
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Familial hypercholesterolemia
- •age 18-50 yrs
- •informed consent
- •BMI 18-30 kg/m2
排除标准
- •previous cardiovascular event
- •acute inflammatory disease
- •anti-inflammatory medication
- •ECG abnormalities
研究者
相似试验
已完成
4 期
Clinical study to study the efficacy and safety of KSM- 66 Ashwagandha (Withania Somnifera) cardiac endurance and Oxidative Stress in Athletes / Sports personsCTRI/2016/04/006791Shri Karthikeya Pharma50
已完成
4 期
Study to evaluate the efficacy and safety of KSM- 66 Ashwagandha on sexual wellness of healthy male subjectsCTRI/2016/05/006906Shri Karthikeya Pharma50
招募中
3 期
Prevention and management of neuropsychiatric and cardiovascular complications by an Ayurvedic formulation among menopausal womeCTRI/2015/01/005365SRM University1,000
已完成
2 期
A randomized double blind placebo controlled clinical trial of buspirone for treating autism spectrum disordersIRCT201307303930N28Shiraz University of Medical sciences40
尚未招募
不适用
Ayurvedic intervention for stress in IT professionalsCTRI/2019/08/020798CCRAS MINISTRY OF AYUSH